KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non-Current Liabilities (2016 - 2025)

Sarepta Therapeutics has reported Other Non-Current Liabilities over the past 14 years, most recently at $1.5 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $1.5 million for Q4 2025, down 96.77% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (down 96.77% YoY), and the annual figure for FY2025 was $1.5 million, down 96.77%.
  • Other Non-Current Liabilities for Q4 2025 was $1.5 million at Sarepta Therapeutics, up from $300000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for SRPT hit a ceiling of $50.8 million in Q1 2021 and a floor of $300000.0 in Q3 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $43.6 million (2021), compared with a mean of $37.7 million.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 395.71% in 2021 and later tumbled 99.37% in 2025.
  • Sarepta Therapeutics' Other Non-Current Liabilities stood at $43.6 million in 2021, then decreased by 15.37% to $36.9 million in 2022, then grew by 3.25% to $38.1 million in 2023, then rose by 24.41% to $47.4 million in 2024, then tumbled by 96.77% to $1.5 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $1.5 million (Q4 2025), $300000.0 (Q3 2025), and $47.4 million (Q2 2025) per Business Quant data.